CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Cumulative effect adjustment due to the adoption of ASC 326, net of tax	Common Stock	Additional Paid in Capital	Retained Earnings (As Restated)	Retained Earnings (As Restated) Cumulative effect adjustment due to the adoption of ASC 326, net of tax	Accumulated Other Comprehensive (Loss) Income
Beginning balance at Dec. 31, 2021	$ 350,693		$ 198	$ 200,473	$ 149,966		$ 56
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	5,613				5,613
Other comprehensive income (loss)	(2,228)						(2,228)
Common shares issued for employee stock purchase plan	37			37
Stock-based compensation	130			130
Cash dividends declared	(2,381)				(2,381)
Ending balance at Mar. 31, 2022	351,864		198	200,640	153,198		(2,172)
Beginning balance at Dec. 31, 2021	350,693		198	200,473	149,966		56
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	22,769
Ending balance at Sep. 30, 2022	357,221		199	201,213	165,590		(9,781)
Beginning balance at Dec. 31, 2021	350,693		198	200,473	149,966		56
Ending balance at Dec. 31, 2022	$ 364,285	$ (7,818)	199	201,494	171,613	$ (7,818)	(9,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Beginning balance at Mar. 31, 2022	$ 351,864		198	200,640	153,198		(2,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	7,499				7,499
Other comprehensive income (loss)	(4,479)						(4,479)
Common shares issued for employee stock purchase plan	102			102
Stock-based compensation	172			172
Cash dividends declared	(2,381)				(2,381)
Ending balance at Jun. 30, 2022	352,777		198	200,914	158,316		(6,651)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	9,658				9,658
Other comprehensive income (loss)	(3,130)						(3,130)
Common shares issued for employee stock purchase plan	125		1	124
Stock-based compensation	175			175
Cash dividends declared	(2,384)				(2,384)
Ending balance at Sep. 30, 2022	357,221		199	201,213	165,590		(9,781)
Beginning balance at Dec. 31, 2022	364,285	(7,818)	199	201,494	171,613	(7,818)	(9,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	6,457				6,457
Other comprehensive income (loss)	860						860
Common shares issued for employee stock purchase plan	87			87
Stock-based compensation	155			155
Cash dividends declared	(2,388)				(2,388)
Ending balance at Mar. 31, 2023	361,638		199	201,736	167,864		(8,161)
Beginning balance at Dec. 31, 2022	364,285	$ (7,818)	199	201,494	171,613	$ (7,818)	(9,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	738
Ending balance at Sep. 30, 2023	501,578		331	355,575	155,781		(10,109)
Beginning balance at Mar. 31, 2023	361,638		199	201,736	167,864		(8,161)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	4,018				4,018
Other comprehensive income (loss)	(400)						(400)
Common shares issued for employee stock purchase plan	102			102
Stock-based compensation	170			170
Cash dividends declared	(2,388)				(2,388)
Ending balance at Jun. 30, 2023	363,140		$ 199	202,008	169,494		(8,561)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(9,737)				(9,737)
Other comprehensive income (loss)	(1,548)						(1,548)
TCFC acquisition (in shares)			132,000
TCFC acquisition	153,086			152,954
Common shares issued for employee stock purchase plan	84			84
Stock-based compensation	529			529
Cash dividends declared	(3,976)				(3,976)
Ending balance at Sep. 30, 2023	$ 501,578		$ 331	$ 355,575	$ 155,781		$ (10,109)